Skip to main content
TipRanks
Go Ultimate75% OFF

Precision System Science Co.,Ltd (7707) AI Stock Analysis

1 Followers
JP:7707

Precision System Science Co.,Ltd

(TSE/TYO:7707)

Select Model
Rating:52Neutral
Price Target:JPY 195.00â–²(4.28% Upside)
Action:reiterated
Date:11/19/26

The score is primarily held back by weak and inconsistent cash flow conversion despite a rebound in reported profitability, alongside a technically weak setup (below key moving averages with negative MACD). A reasonable P/E and modest dividend provide partial offset.

Positive Factors
Automation and consumables platformThe combination of laboratory automation platforms and proprietary consumables supports standardized, high-throughput workflows in clinical and research settings. This integrated offering can encourage repeat usage, deepen customer process integration, and provide a durable base for ongoing demand beyond individual equipment sales.
Negative Factors
Weak cash conversionThe wide gap between reported earnings and operating cash flow, together with negative free cash flow, weakens confidence that the profit recovery is translating into internally generated funds. Continued cash shortfalls could increase funding dependence and restrict investment flexibility.

Precision System Science Co.,Ltd (7707) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%40%50%JP:7707-4.10%EWJ+6.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 5.03B
Dividend Yield
1.07%
Average Volume (3M)
122.45K
Price to Earnings (P/E)
11.0
Beta (1Y)
0.96
Revenue Growth
9.27%
EPS Growth
―
Country
Japan
Employees
129
Sector
Healthcare
Sector Strength
51
Industry
Medical - Diagnostics & Research

Precision System Science Co.,Ltd Business Overview & Revenue Model

Company Description

Precision System Science Co., Ltd. (PSS), along with its subsidiaries, specializes in the development, production, and global distribution of automated and physicochemical instruments, software, and various related goods, serving both the Japanese do...

Precision System Science Co.,Ltd Financial Statement Overview

Summary

Income statement and balance sheet show improvement (profitability rebounded in 2026 and leverage is manageable), but cash flow quality is a major concern: operating cash flow was modest versus net income and free cash flow turned negative, with a multi-year pattern of inconsistent cash conversion. This reduces confidence in the durability of the earnings recovery.

Income Statement

58Neutral

Balance Sheet

68Positive

Cash Flow

34Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue5.22B5.22B4.69B3.98B5.28B7.43B
Gross Profit1.58B1.58B1.38B950.38M1.35B2.49B
EBITDA411.95M409.05M10.06M-661.75M-594.05M740.33M
Net Income394.87M394.87M-253.10M-1.12B-1.32B45.34M
Balance Sheet
Total Assets5.85B5.85B4.94B6.40B9.76B11.41B
Cash, Cash Equivalents and Short-Term Investments1.37B1.37B1.04B1.92B2.45B2.76B
Total Debt1.03B1.03B564.21M1.37B3.88B4.03B
Total Liabilities1.76B1.76B1.18B2.25B4.54B4.90B
Stockholders Equity4.09B4.09B3.76B4.14B5.22B6.51B
Cash Flow
Free Cash Flow0-50.57M43.24M-130.81M-162.03M-1.38B
Operating Cash Flow051.41M95.83M-106.80M-6.75M869.16M
Investing Cash Flow0-98.03M-8.24M2.06B-213.70M-2.29B
Financing Cash Flow0460.79M-910.82M-2.51B-154.05M93.73M

Precision System Science Co.,Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price187.00

Price Trends

50DMA206.36Negative
100DMA206.88Negative
200DMA217.00Negative

Market Momentum

MACD-4.98Negative
RSI42.31Neutral
STOCH50.88Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7707, the sentiment is Negative. The current price of 187.00 is below the 20-day moving average (MA) of 197.20, below the 50-day MA of 206.36, and below the 200-day MA of 217.00, indicating a bearish trend. The MACD of -4.98 indicates Negative momentum. The RSI at 42.31 is Neutral, neither overbought nor oversold. The STOCH value of 50.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7707.

Precision System Science Co.,Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:7707 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4570JP:457068NeutralJPY 8.48B21.17―0.71%7.10%17.17%
JP:3386JP:338667NeutralJPY 6.97B20.67―4.16%7.17%36.23%
JP:7707JP:770752NeutralJPY 5.34B10.99―1.07%9.27%―
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:4978JP:497845NeutralJPY 11.75B-24.14――-8.23%-48.10%
JP:4892JP:489242NeutralJPY 5.08B-6.33――214.65%22.18%
JP:7776JP:777637UnderperformJPY 6.07B-4.61――-49.43%-3.77%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%150%JP:7707JP:3386JP:4570JP:4892JP:4978JP:7776Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7707 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7707Precision System Science Co.,Ltd187.00-8.00-4.10%
JP:3386Cosmo Bio Co., Ltd.1201.00-124.22-9.37%
JP:4570Immuno-Biological Laboratories Co., Ltd.850.00-562.94-39.84%
JP:4892Cyfuse Biomedical K.K.487.00-83.00-14.56%
JP:4978ReproCELL Inc.105.00-50.00-32.26%
JP:7776CellSeed Inc.142.00-152.00-51.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 19, 2026